Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Profit After Tax: 2009-2024

Historic Profit After Tax for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to $880,000.

  • Ironwood Pharmaceuticals' Profit After Tax rose 999.29% to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 1014.74%. This contributed to the annual value of $880,000 for FY2024, which is 100.09% up from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Profit After Tax of $880,000 as of FY2024, which was up 100.09% from -$1.0 billion recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Profit After Tax ranged from a high of $528.4 million in FY2021 and a low of -$1.0 billion during FY2023.
  • Over the past 3 years, Ironwood Pharmaceuticals' median Profit After Tax value was $880,000 (recorded in 2024), while the average stood at -$285.2 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 397.71% in 2021, then slumped by 689.24% in 2023.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' Profit After Tax stood at $106.2 million in 2020, then spiked by 397.71% to $528.4 million in 2021, then crashed by 66.87% to $175.1 million in 2022, then slumped by 689.24% to -$1.0 billion in 2023, then surged by 100.09% to $880,000 in 2024.